A (relatively) risky business: the link between prostatic radiotherapy and second malignancies.

Eyler, Christine E; Zietman, Anthony L · BMJ · 2016

editorial · Level V

Where this comes from

Abstract

Unlikely to change therapeutic decisions for most men with high grade prostate cancer

Medical subject headings